HPS-103 - Off-label use of imiquimod for the treatment of oral leukoplakia: A case report

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-103
• By: LIU, Chientzu (E-da Hospital, China Taiwan)
• Co-author(s): Ms Chientzu Liu (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  Mr. Yungjun Hung (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  Mr. Yungchia Hsu (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  
• Abstract:

  Background
  Imiquimod cream is a skin and mucous membrane agent that modulates the immune response by inducing interferon production. It is commonly used to treat external genital and perianal warts, including condyloma acuminata. Oral leukoplakia is a potentially malignant disorder (PMD) of the oral mucosa, presenting as white patches, and is..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login